ArticleInternational journal of pharmaceutics: X2024

Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cells.

Shaghayegh Saharkhiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.